Skip to main content
Erschienen in: Supportive Care in Cancer 9/2005

01.09.2005 | Short Communication

Correlation between “malfunctioning events” and catheter-related infections in pediatric cancer patients bearing tunneled indwelling central venous catheter: results of a prospective observational study

verfasst von: Elio Castagnola, Giuseppe Fratino, Mariangela Valera, Mareva Giacchino, Riccardo Haupt, Angelo Claudio Molinari

Erschienen in: Supportive Care in Cancer | Ausgabe 9/2005

Einloggen, um Zugang zu erhalten

Abstract

Aim of the study

To evaluate the possible link between malfunctioning events and catheter related infections in indwelling central venous devices in children with cancer.

Patients and methods

Prospective observation of 418 devices inserted in 2 Italian tertiary care pediatric cancer centers. The presence of a relationship was identified if a malfunctioning event was followed by a catheter related infection within 10 days, or vice versa.

Results

The 418 catheters were followed for a period of 107,012 days. Among the malfunctioning events 2 out of 141 (1%) were followed by a catheter related infection while among infectious episodes 3 out of 93 (3%) were followed by a malfunctioning event.

Conclusions

Malfunctioning events followed by catheter related infections and catheter related infections followed by malfunctioning are both rare events in children with cancer.
Literatur
1.
Zurück zum Zitat Castagnola E, Molinari AC, Fratino G, Viscoli C (2003) Conditions associated with infections of indwelling central venous catheters in cancer patients: a summary. Br J Haematol 121:233–239PubMed Castagnola E, Molinari AC, Fratino G, Viscoli C (2003) Conditions associated with infections of indwelling central venous catheters in cancer patients: a summary. Br J Haematol 121:233–239PubMed
2.
Zurück zum Zitat Crnich CJ, Maki DG (2002) The promise of novel technology for prevention of intravascular device related bloodstream infections. II. Long term devices. Clin Infect Dis 34:1362–1368 Crnich CJ, Maki DG (2002) The promise of novel technology for prevention of intravascular device related bloodstream infections. II. Long term devices. Clin Infect Dis 34:1362–1368
3.
Zurück zum Zitat Darouiche RO (2001) Device associated infections: a macroproblem that starts with microadherence. Clin Infect Dis 33:1567–1572 Darouiche RO (2001) Device associated infections: a macroproblem that starts with microadherence. Clin Infect Dis 33:1567–1572
4.
Zurück zum Zitat De Pauw B, Meunier F (2000) Infections in patients with acute leukemia and lymphoma. In: Mandell GL, Bennett JB, Dolin R (eds) Mandell, Douglas and Bennett’s principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 3090–3102 De Pauw B, Meunier F (2000) Infections in patients with acute leukemia and lymphoma. In: Mandell GL, Bennett JB, Dolin R (eds) Mandell, Douglas and Bennett’s principles and practice of infectious diseases. Churchill Livingstone, Philadelphia, pp 3090–3102
5.
Zurück zum Zitat Donlan RM (2001) Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33:1387–1393 Donlan RM (2001) Biofilm formation: a clinically relevant microbiological process. Clin Infect Dis 33:1387–1393
6.
Zurück zum Zitat Fratino G, Mazzola C, Buffa P, Torre M, Castagnola E, Magillo P et al (2001) Mechanical complications related to indwelling central venous catheter in hematology/oncology patients. Pediatr Hematol Oncol 18:317–324 Fratino G, Mazzola C, Buffa P, Torre M, Castagnola E, Magillo P et al (2001) Mechanical complications related to indwelling central venous catheter in hematology/oncology patients. Pediatr Hematol Oncol 18:317–324
7.
Zurück zum Zitat Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, Haupt R (2005) Central venous catheter related complications in children with oncological/hematological diseases: an observational study on 418 devices. Ann Oncol. [Epub ahead of print] Fratino G, Molinari AC, Parodi S, Longo S, Saracco P, Castagnola E, Haupt R (2005) Central venous catheter related complications in children with oncological/hematological diseases: an observational study on 418 devices. Ann Oncol. [Epub ahead of print]
8.
Zurück zum Zitat Journeycake JM, Buchanan GR (2003) Thrombotic complications of central venous catheters in children. Curr Opin Hematol 10:369–374 Journeycake JM, Buchanan GR (2003) Thrombotic complications of central venous catheters in children. Curr Opin Hematol 10:369–374
9.
Zurück zum Zitat Mermel LA (2000) Prevention of intravascular catheter related infections. Ann Intern Med 132:391–402PubMed Mermel LA (2000) Prevention of intravascular catheter related infections. Ann Intern Med 132:391–402PubMed
10.
Zurück zum Zitat Molinari AC, Castagnola E, Mazzola C, Piacentino M, Fratino G (2001) Thromboembolic complications related to indwelling central venous catheters in children with oncological/haematological diseases: a retrospective study on 362 catheters. Support Care Cancer 9:539–544CrossRefPubMed Molinari AC, Castagnola E, Mazzola C, Piacentino M, Fratino G (2001) Thromboembolic complications related to indwelling central venous catheters in children with oncological/haematological diseases: a retrospective study on 362 catheters. Support Care Cancer 9:539–544CrossRefPubMed
11.
Zurück zum Zitat O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Dennis G, Maki DG et al (2002) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 35:1281–1307CrossRef O’Grady NP, Alexander M, Dellinger EP, Gerberding JL, Heard SO, Dennis G, Maki DG et al (2002) Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis 35:1281–1307CrossRef
12.
Zurück zum Zitat Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP (1994) The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 271:1014–1016 Raad II, Luna M, Khalil SA, Costerton JW, Lam C, Bodey GP (1994) The relationship between the thrombotic and infectious complications of central venous catheters. JAMA 271:1014–1016
13.
Zurück zum Zitat Tolar B, Gould JR (1996) The timing and sequence of multiple device related complications in patients with long term indwelling Groshong catheters. Cancer 78:1308–1313 Tolar B, Gould JR (1996) The timing and sequence of multiple device related complications in patients with long term indwelling Groshong catheters. Cancer 78:1308–1313
14.
Zurück zum Zitat Viscoli C, Castagnola E, Giacchino M, Cesaro S, Properzi E, Tucci F et al (1999) Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group Infectious Diseases Section. Eur J Cancer 35:770–774CrossRefPubMed Viscoli C, Castagnola E, Giacchino M, Cesaro S, Properzi E, Tucci F et al (1999) Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group Infectious Diseases Section. Eur J Cancer 35:770–774CrossRefPubMed
Metadaten
Titel
Correlation between “malfunctioning events” and catheter-related infections in pediatric cancer patients bearing tunneled indwelling central venous catheter: results of a prospective observational study
verfasst von
Elio Castagnola
Giuseppe Fratino
Mariangela Valera
Mareva Giacchino
Riccardo Haupt
Angelo Claudio Molinari
Publikationsdatum
01.09.2005
Erschienen in
Supportive Care in Cancer / Ausgabe 9/2005
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-005-0802-y

Weitere Artikel der Ausgabe 9/2005

Supportive Care in Cancer 9/2005 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.